Chemistry

A.M. Klibanov, Asymmetric transformations cataluzed by enzymes in organic solvents, Accounts of Chemical Research, 23:114-120, 1990. Alexander M. Kilbanov (Massachusetts Institute of Technology, Cambridge): Recent studies have firmly established that, in contrast to the conventional wisdom, enzymes can work as catalysts in organic solvents containing little or no water. Not only do enzymes retain their catalytic integrity in such media, but also, when placed in this unnatural milieu, they exhi

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A.M. Klibanov, Asymmetric transformations cataluzed by enzymes in organic solvents, Accounts of Chemical Research, 23:114-120, 1990.

Alexander M. Kilbanov (Massachusetts Institute of Technology, Cambridge): Recent studies have firmly established that, in contrast to the conventional wisdom, enzymes can work as catalysts in organic solvents containing little or no water. Not only do enzymes retain their catalytic integrity in such media, but also, when placed in this unnatural milieu, they exhibit remarkable properties such as greatly enhanced thermostability, radically altered substrated and stereo specificities, molecular memory, and the ability to catalyze new reactions. Conseqently, numerous exciting applications of enzymes as catalysts in organic chemisry are emerging, including facile resolution of racemic mixtures, synthesis of optically active compounds, reioselective modfication of sugars and steroids, asymmetric oxidoreductions, peptide synthesis, polymerization processes. Enzymatic catalysis in organic solvents should benefit industrial production of pharmaceutical compounds, novel food ingredients, and advanced materials."

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies